MEET US 2026
Making Pharma Spain: Barcelona, ES | 18-19 Feb 2026
|
PharmaForum: Mainz, DE | 05 Mar 2026
|
KOREA PHARM & BIO: Seoul, KR | 31 Mar – 03 Apr 2026
|
Cell & Gene Meeting on the Med: Rome, IT | 28-30 Apr 2026
|
BIO KOREA 2026: Seoul, KR | 28-30 Apr 2026
|
Swiss Biotech Days: Basel, CH | 04-05 May 2026
|
Partnering Day Mabdesign: Lyon, FR | 12 May 2026
|
ICGT Congress: Gentilly, FR | 27-28 May 2026
|
Simposio AFI: Rimini, IT | 10-12 Jun 2026
|
Antibody Industrial Symposium: Montpellier, FR | 30 Jun – 01 Jul 2026
|
BIO Asia-Taiwan Exhibition: Taipei, TW | 16-19 Jul 2026
|
CPHI 2026: Milan, IT | 06-08 Oct 2026
logo-dark

CMC

All about CMC

Learn about CMC analysis & quality control news and their importance to ensure precision, quality and safety when developing new pharmaceutical products.

Biosimilar Development: From Phase III to Analytical Comparability and PK/PD

Although the development of biosimilars has historically been difficult, expensive, [...]

By |2025-11-07T08:38:16+01:007. November 2025|Bioanalysis, CMC|Comments Off on Biosimilar Development: From Phase III to Analytical Comparability and PK/PD

Liraglutide & Semaglutide: Exploring Biosimilar Studies for GLP-1 receptor agonists

Liraglutide and Semaglutide have become key players in the pharmaceutical [...]

By |2025-10-30T14:02:29+01:0020. February 2024|Bioanalysis, CMC|Comments Off on Liraglutide & Semaglutide: Exploring Biosimilar Studies for GLP-1 receptor agonists

Impurity Profiling: Characterization of unknown impurities in pharmaceuticals

Characterization of unknown impurities found in pharmaceutical substances and pharmaceutical [...]

By |2024-08-29T11:46:18+02:0023. January 2024|CMC|Comments Off on Impurity Profiling: Characterization of unknown impurities in pharmaceuticals
Go to Top